Vaccinex Inc VCNX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 AM EDT
7.47quote price arrow up+0.04 (+0.54%)
Volume
150
Close
7.43quote price arrow up+0.53 (+7.68%)
Volume
34,747
52 week range
4.43 - 99.75
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close7.43
  • 52 Week High99.75
  • 52 Week High Date06/12/23
  • 52 Week Low4.43
  • 52 Week Low Date04/18/24

Key Stats

  • Market Cap11.771M
  • Shares Out1.58M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta0.92
  • YTD % Change-20.17

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close7.43
  • 52 Week High99.75
  • 52 Week High Date06/12/23
  • 52 Week Low4.43
  • 52 Week Low Date04/18/24
  • Market Cap11.771M
  • Shares Out1.58M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta0.92
  • YTD % Change-20.17

RATIOS/PROFITABILITY

  • EPS (TTM)-46.03
  • P/E (TTM)-0.16
  • Fwd P/E (NTM)-6.58
  • EBITDA (TTM)-22.858M
  • ROE (TTM)-1,004.77%
  • Revenue (TTM)123,999.998
  • Gross Margin (TTM)-
  • Net Margin (TTM)-15,472.58%
  • Debt To Equity (MRQ)3.09%

EVENTS

  • Earnings Date08/17/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Vaccinex Inc

 

Profile

MORE
Vaccinex, Inc. is a clinical-stage biotechnology company. The Company is engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including neurodegenerative diseases, cancer, and autoimmune disorders. Its lead product candidate, pepinemab, is in clinical development for the treatment of Alzheimer’s disease, head and neck, pancreatic and breast cancer. Its lead platform technologies include SEMA4D...
Albert Friedberg
Chairman of the Board
Maurice Zauderer Ph.D.
President, Chief Executive Officer, Director
Elizabeth Evans Ph.D.
Chief Operating Officer, Senior Vice President - Discovery and Translational Medicine
Jill Sanchez
Interim Chief Financial Officer
Address
1895 Mount Hope Ave
Rochester, NY
14620-4540
United States

Top Peers

SYMBOLLASTCHG%CHG
CANF
Can Fite Biopharma Ltd
2.47-0.09-3.39%
LGVN
Longeveron Inc
1.04-0.01-0.95%
NTBL
Notable Labs Ltd
0.855-0.05-5.5249%
ABVC
ABVC Biopharma Inc
0.777-0.012-1.5209%
ADXS
Ayala Pharmaceuticals Inc
0.25UNCHUNCH